tyc122ccvip

ActiveMax® Human DLL4 μBeads, premium grade (for cells)
DMF

用户评价
货号-规格
价格
Qty.
MBS-C013-2.5mg
¥18775.00
MBS-C013-10mg
¥46085.00
合计0件 tyc122ccvip金额¥ 0

tyc122ccvip详情

  • Product
    Size
    Amount
    ActiveMax® Human DLL4 μBeads, premium grade (for cells)
    2.5 mg
    2.5×10⁷ beads
    ActiveMax® Human DLL4 μBeads, premium grade (for cells)
    10 mg
    1×10⁸ beads
  • tyc122ccvip描述(Product Description)

    ActiveMax® Human DLL4 μBeads, premium grade (for cells) are uniform, superparamagnetic beads of 5.5 µm in diameter immobilized with Human DLL4 Protein, expressed from human 293 cells (HEK293) and contains AA Ser 27 - Pro 524 (Accession # NP_061947.1 ).
    ActiveMax® Human DLL4 μBeads, premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5) , and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

  • 应用说明(Application)

    ActiveMax® Human DLL4 μBeads, premium grade (for cells) can activate Notch signaling in hematopoietic stem/progenitor cells (HSPCs), mimicking DLL4+ epithelial cells in the thymus, and then drives T-lineage commitment and differentiation. It can be used for in vitro production of induced pluripotent stem cell derived T cells, such as inducing the differentiation from CD34+ cells to progenitor T cells to TCRαβ T cells in vitro, which provides a simple and robust tool to both study human T cell development and facilitate the development of engineered T cell therapies from renewable sources.

  • 重构方法(Reconstitution)

    See Certificate of Analysis (CoA) for detailed instruction.

  • 存储(Storage)

    This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.

    Please avoid repeated freeze-thaw cycles after reconstitution. Immediate use after reconstitution is highly recommended.

  • 无菌(Sterility)

    Negative

  • 内毒素(Endotoxin)

    Less than 0.002 EU per μg by the LAL method / rFC method.

  • 支原体(Mycoplasma)

    Negative

  • 注意事项(Important Note)

    This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

  • 制剂(Formulation)

    Please contact us for detailed information.

    Contact us for customized product form or formulation.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐tyc122ccvip

数据展示

  • 流式数据 -FACS Data

     DLL4 FACS

    Assay of human DLL4 protein on the μBeads surface by Flow cytomtry.The human DLL4 conjugated on the μBeads (Cat. No. MBS-C013) surface were fluorescently stained using Human Anti-DLL4 Antibody, Mouse IgG1 and PE labeled anti-Mouse IgG1 Antibody, analyzed by flow cytometry (QC tested).

    Protocol
  • 应用数据(Application Data)

     DLL4 APPLICATION DATA

    ActiveMax® Human DLL4 μBeads, premium grade (for cells) (Cat. No. MBS-C013) could efficiently induce hematopoietic stem cell differentiation into CD56+ NK cells after 25 days of culture, with high expression of CD56, NKp46, NKp30, and NKp44.

  •  DLL4 APPLICATION DATA

    The Cell Number of hcCD34P cells-derived CD7+ and CD5+ T-lymphoid progenitors After 21 Days of Culture. Combinations of ActiveMax® Human DLL4 μBeads, premium grade(for cells)(Cat.No.MBS-C013) and Cytokine could efficiently induce hcCD34P cells differentiation into CD7+ and CD5+ T-lymphoid progenitors after 21 days of culture.

  •  DLL4 APPLICATION DATA

    CD34+ CD45+ hematopoietic cells were co-cultured with Human DLL4 μBeads (Cat. No. MBS-C013) and differentiated over a 14-day period. Subsequent flow cytometric analysis was performed to evaluate the expression of T-cell progenitor markers CD5 and CD7. The results indicated that Human DLL4 μBeads (Cat. No. MBS-C013), in combination with supplementary growth factors, effectively promoted the differentiation of CD7+ cells as well as CD5+CD7+ double-positive T-cell progenitors. The induction efficiency was enhanced as the cell-to-bead ratio increased from 1:3 to 1:40. Based on both induction performance and cost-effectiveness, a cell-to-bead ratio of approximately 1:20 is recommended.

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Delta-like protein 4

  • 中文全称:

    δ样蛋白-4

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    3 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • tyc122ccvip基础信息
  • tyc122ccvip详情
  • 推荐tyc122ccvip
  • 数据展示
  • 用户评价